Opioid antagonists and butorphanol dependence
- 31 March 1993
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 44 (3) , 497-500
- https://doi.org/10.1016/0091-3057(93)90158-p
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The physical dependence liability of butorphanol: A comparative study with morphineEuropean Journal of Pharmacology, 1991
- Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociceptionEuropean Journal of Pharmacology, 1991
- Autoradiographic study of irreversible binding of [3H]β-funaltrexamine to opioid receptors in the rat forebrain: comparison with μ and δ receptor distributionBrain Research, 1991
- Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphinePharmacology Biochemistry and Behavior, 1991
- Butorphanol's efficacy at mu and kappa opioid receptors: Interences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedurePharmacology Biochemistry and Behavior, 1990
- Comparative pharmacological and biochemical studies between butorphanol and morphinePharmacology Biochemistry and Behavior, 1989
- Application of the message-address concept in the design of highly potent and selective non-peptide .delta. opioid receptor antagonistsJournal of Medicinal Chemistry, 1988
- Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonistEuropean Journal of Pharmacology, 1988
- Stadol dependence: another casePublished by American Medical Association (AMA) ,1985
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980